E2 ModeratePreliminaryPEM not requiredLongitudinalPeer-reviewedMachine draft
Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology.
Stringer, Elizabeth Ann, Baker, Katharine Susanne, Carroll, Ian R et al. · Journal of translational medicine · 2013 · DOI
Quick Summary
This study tracked blood samples and fatigue reports from 10 people with ME/CFS and 10 healthy people over 25 days. Researchers found that a hormone called leptin—which controls hunger and immune function—was linked to daily changes in fatigue severity in people with ME/CFS. A computer program analyzing all measured immune markers could correctly identify high fatigue days versus low fatigue days about 78% of the time, suggesting the immune system plays a real role in ME/CFS symptoms.
Why It Matters
Most prior ME/CFS research relied on single blood draws, potentially missing the fluctuating nature of the illness. This study's finding that immune markers—particularly leptin—correlate with daily fatigue changes suggests inflammatory mechanisms may directly drive symptom variability, opening new avenues for tracking disease severity and developing treatments targeted at immune dysregulation.
Observed Findings
- Daily fatigue severity correlated significantly with leptin levels in 6 of 10 CFS participants versus only 1 of 10 healthy controls.
- A machine learning model using all 51 cytokine measurements distinguished high from low fatigue days in the CFS group with 78.3% accuracy.
- The study documented substantial day-to-day variability in fatigue severity within individual CFS patients over the 25-day monitoring period.
- Multiple cytokines showed dysregulation patterns in CFS participants when tracked longitudinally.
Inferred Conclusions
- Cytokines, particularly the adipokine leptin, appear to play a role in CFS pathophysiology and may help explain day-to-day fatigue fluctuations.
- Immune dysregulation in CFS may be dynamic rather than static, requiring longitudinal rather than single time-point assessment.
- Immune markers collectively have potential utility in distinguishing high from low symptom severity days in ME/CFS.
Remaining Questions
- Does leptin directly cause fatigue, or is it a marker of a broader inflammatory cascade that does?
- Would these findings replicate in a larger, more diverse cohort (including males and different age groups)?
- Can the 78% machine learning accuracy be validated prospectively in independent participants, and could it form the basis of a clinical monitoring tool?
What This Study Does Not Prove
This study does not prove that leptin or cytokines *cause* fatigue—only that they are associated with it; causation requires additional evidence. The small sample size (10 participants per group) means findings may not generalize to all ME/CFS patients or to males. The 78% machine learning accuracy, while promising, does not establish a clinical biomarker suitable for diagnosis without validation in independent cohorts.
Tags
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1186/1479-5876-11-93
- PMID
- 23570606
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →